We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-3.84%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$6.16B
AUM Growth
+$1.7B
Cap. Flow
+$2.17B
Cap. Flow %
35.15%
Top 10 Hldgs %
26.62%
Holding
7,028
New
630
Increased
3,221
Reduced
2,151
Closed
574

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$204M
2
MSFT icon
Microsoft
MSFT
+$195M
3
AMZN icon
Amazon
AMZN
+$97.4M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$95M
5
TSM icon
TSMC
TSM
+$69.5M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$53M
2
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$26.7M
3
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$23.7M
4
IWD icon
iShares Russell 1000 Value ETF
IWD
+$19.5M
5
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$15M

Sector Composition

Rank Sector Weight
1 Technology 27%
2 Healthcare 10.88%
3 Consumer Discretionary 10.71%
4 Financials 8.69%
5 Communication Services 7.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NOTV
3551
DELISTED
Inotiv
NOTV
$32K ﹤0.01%
1,875
-3,242
-63% -$59.5K
NRC icon
3552
NRC Health Common Stock
NRC
$469M
$32K ﹤0.01%
783
+144
+23% +$5.33K
QSI icon
3553
Quantum-Si Incorporated
QSI
$161M
$32K ﹤0.01%
11,312
-3,284
-22% -$10.5K
RBB icon
3554
RBB Bancorp
RBB
$467M
$32K ﹤0.01%
1,525
-764
-33% -$16.6K
REAL icon
3555
The RealReal
REAL
$1.39B
$32K ﹤0.01%
21,688
+9,647
+80% +$23.3K
RLMD icon
3556
Relmada Therapeutics
RLMD
$512M
$32K ﹤0.01%
852
-617
-42% -$17.1K
TK icon
3557
Teekay
TK
$1.09B
$32K ﹤0.01%
8,823
-319
-3% -$1.06K
UONE icon
3558
Urban One Class A
UONE
$23.3M
$32K ﹤0.01%
595
+393
+195% +$22K
VUZI icon
3559
Vuzix
VUZI
$258M
$32K ﹤0.01%
5,573
+2,688
+93% +$20.7K
XPRO icon
3560
Expro Ltd
XPRO
$2.1B
$32K ﹤0.01%
2,495
-149
-6% -$1.81K
MAGN
3561
Magnera Corp
MAGN
$444M
$32K ﹤0.01%
789
+15
+2% +$1.04K
HTB
3562
HomeTrust Bancshares
HTB
$834M
$32K ﹤0.01%
1,482
+784
+112% +$18.9K
FFAI
3563
Faraday Future Intelligent Electric
FFAI
$10M
– –
0
– –
ENFN
3564
DELISTED
Enfusion, Inc.
ENFN
$32K ﹤0.01%
2,532
+189
+8% +$2.31K
PIXY
3565
DELISTED
ShiftPixy, Inc. Common Stock
PIXY
$32K ﹤0.01%
7
+6
+600% +$46.9K
ZLSWU
3566
DELISTED
Zalatoris II Acquisition Corp Unit
ZLSWU
$32K ﹤0.01%
3,229
+80
+3% +$784
AKLI
3567
DELISTED
Akili Inc
AKLI
$32K ﹤0.01%
14,206
+12,640
+807% +$90.6K
RVLP
3568
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$32K ﹤0.01%
+15,483
New +$30.1K
MMP
3569
DELISTED
Magellan Midstream Partners, L.P.
MMP
$32K ﹤0.01%
682
-4,019
-85% -$202K
ACEL icon
3570
Accel Entertainment
ACEL
$1.01B
$31K ﹤0.01%
3,907
+2,063
+112% +$21K
BCSF icon
3571
Bain Capital Specialty
BCSF
$814M
$31K ﹤0.01%
2,613
+2,364
+949% +$33.7K
BWB icon
3572
Bridgewater Bancshares
BWB
$620M
$31K ﹤0.01%
1,844
+935
+103% +$16K
ECC
3573
Eagle Point Credit Company
ECC
$510M
$31K ﹤0.01%
2,843
+2,363
+492% +$27.3K
FHTX icon
3574
Foghorn Therapeutics
FHTX
$372M
$31K ﹤0.01%
3,687
+1,767
+92% +$22.7K
FLL icon
3575
Full House Resorts
FLL
$81.7M
$31K ﹤0.01%
5,544
-7,291
-57% -$47K
141 142
143
144 145

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2022 Portfolio in Review

As of Q3 2022, Tower Research Capital (TRC) held 7,028 positions worth $6.16B, up 38% from $4.46B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $2.17B of net new capital in Q3 2022, opening 630 new positions and adding to 3,221 existing holdings. Its largest new stake was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $53M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2022 buy was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.
  • Tower Research Capital (TRC) added most to Apple in Q3 2022, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $53M.
  • Tower Research Capital (TRC) fully exited State Street SPDR Portfolio S&P 500 ETF in Q3 2022, selling an estimated $6.39M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $6.16B portfolio in Q3 2022.
  • Tower Research Capital (TRC) opened 630 new positions and closed 574 in Q3 2022.
  • Tower Research Capital (TRC)'s portfolio value rose 38% quarter-over-quarter to $6.16B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2022, filed 10 Nov 2022.